Compugen Ltd diagnostics interface makes it easy to digest most current publicly released information about Compugen Ltd as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Compugen Ltd price relationship with some important fundamental indicators such as market cap and management efficiency.
Compugen Ltd Note
The company recorded loss per share of 0.42. Compugen Ltd had not issued any dividends in recent years. Compugen Ltd., a therapeutic discovery company, engages in the research, development, and commercialization of therapeutic and product candidates in Israel and Europe. The company was incorporated in 1993 and is headquartered in Holon, Israel. Compugen Ltd operates under Biotechnology classification in Israel and is traded on Tel Aviv Stock Exchange. It employs 101 people. For more info on COMPUGEN please contact Anat CohenDayag at 972 3 765 8585 or go to http://www.cgen.com.
Compugen Ltd Alerts
|Compugen Ltd generates negative expected return over the last 30 days|
|Compugen Ltd has high likelihood to experience some financial distress in the next 2 years|
|The company reported revenue of 17.8M. Net Loss for the year was (22.51M) with profit before overhead, payroll, taxes, and interest of 489K.|
|COMPUGEN has accumulated about 34.9M in cash with (23.45M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.61.|
Market CapitalizationThe company currently falls under 'Small-Cap' category with current market capitalization of 671.89M.
ProfitablityThe company has Profit Margin (PM) of (126.46) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (128.86) % which suggests for every $100 dollars of sales it generated a net operating loss of -1.29.
Management EfficiencyCompugen Ltd has return on total asset (ROA) of (29.22) % which means that it has lost $29.22 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (59.11) % meaning that it generated substantial loss on money invested by shareholders.
Stock Holders for Compugen Ltd
Technical DriversCompugen Ltd shows Risk Adjusted Performance of
Compugen Ltd Price Movement Analysis
Compugen Ltd Predictive Indicators
|Daily Balance Of Power||(1.11)|
|Rate Of Daily Change||0.954|
|Day Median Price||1073.0|
|Day Typical Price||1068.0|
|Market Facilitation Index||0.0011|
|Price Action Indicator||(40.50)|
Compugen Ltd Forecast Models
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
|All Next||Launch My Watchlist Analysis|
Also Currentnly Active
Purchased over 90 shares of
Purchased over 90 shares of
Check also Trending Equities. Please also try Idea Breakdown module to analyze constituents of all macroaxis ideas. macroaxis investment ideas are predefined, sector-focused investing themes.